{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/8cf4cec7-5a0f-49c5-8ec9-36941b5c6b6e/6527efabd40c9700126361cd?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Age1’s Alex Colville: “Inventing the anti-ageing pill”","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/61ba0b311a8cbef1d93cf121/1727779842618-d672e139-a2fe-439d-96ff-688df040c39a.jpeg?height=200","description":"<p>The Sunday Times’ tech correspondent Danny Fortson brings on Alex Colville, co-founder of Age1, to talk about funding longevity science (3:15), studying the biology of ageing (5:10), the snake oil problem (11:05),&nbsp; the rise of “geroscience” (15:15), healthspan (23:05), the ageing hypothesis (26:55), the potential of metformin (30:05), working on an anti-ageing treatment (34:15), and how long he thinks we’ll live (38:45). </p>","author_name":"The Sunday Times"}